Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jaymin JhaveriYuan LiuMudit ChowdharyZachary S BuchwaldTheresa W GillespieJeffrey J OlsonAlfredo D VoloschinBree R EatonHui-Kuo G ShuIan R CrockerWalter J CurranKirtesh R PatelPublished in: Cancer (2017)
No long-term OS difference was seen in patients with high-risk grade 2 gliomas treated with CA versus CRT. These findings are hypothesis-generating, and prospective clinical trials comparing these treatment paradigms are warranted. Cancer 2018;124:1169-78. © 2017 American Cancer Society.